Related Experiment Videos
Hemoglobin A1c in normal and diabetic pregnancy.
JAMA
|December 21, 1979
Summary
Hemoglobin A1c (HbA1c) testing in pregnancy did not predict glucose issues or birth weight. However, HbA1c levels reflected long-term diabetes control in insulin-dependent pregnant patients.
Area of Science:
- Endocrinology
- Obstetrics
- Diabetes Mellitus Research
Background:
- Glycemic control during pregnancy is crucial for maternal and infant outcomes.
- Hemoglobin A1c (HbA1c) is a marker for long-term glucose control.
Purpose of the Study:
- To evaluate the utility of HbA1c levels in predicting maternal glucose intolerance and infant birth weight.
- To assess the correlation between HbA1c and long-term diabetes control in pregnant insulin-dependent individuals.
Main Methods:
- Prospective evaluation of HbA1c levels in pregnant patients.
- Correlation analysis between HbA1c values and maternal glucose tolerance, infant birth weight, and diabetes control.
Main Results:
- HbA1c levels did not predict abnormal maternal glucose tolerance.
- HbA1c values did not correlate with infant birth weight.
- A correlation was observed between HbA1c levels and long-term diabetes control in insulin-dependent pregnant patients.
- A slight decrease in HbA1c was noted as pregnancy progressed, attributed to improved diabetes management.
Conclusions:
- HbA1c is not a reliable predictor of glucose intolerance or birth weight in pregnancy.
- HbA1c serves as a valuable indicator of long-term diabetes management in pregnant insulin-dependent individuals.
- Pregnancy may be associated with improved diabetes control, reflected in decreasing HbA1c levels.